HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

UI Boustead REIT Secures Long Term Lead In Aerospace Sector

Why UI Boustead REIT’s Aerospace Move is a Game Changer for Investors UI Boustead REIT...
SGX-LISTED COMPANIES

Jason Marine Group FY2026 Sees Huge Profit Surge Through Efficiency

Decoding Jason Marine Group’s 70% Profit Surge 2.7% and 70.8%—two figures that shouldn't belong in...
SGX-LISTED COMPANIES

The Two Segments Powering Addvalue Technologies FY2026 Growth

Addvalue’s FY2026 Results Demand Attention Addvalue Technologies FY2026 results serve as a compelling case study...
SGX-LISTED COMPANIES

EuroSports Global Balances Luxury Heritage With Electric Technology – FY2026

4 Surprising Takeaways from EuroSports Global’s FY2026 Results The world of ultra-luxury automobiles is often...
SGX-LISTED COMPANIES

The 37% Revenue Drop For Bukit Sembawang Estates FY2026 Doesn’t Matter

Why Investors Are Cheering Their FY2026 Results In the world of equity analysis, a 37%...
SGX-LISTED COMPANIES

The Truth Behind Singtel’s S$5.6 Billion Net Profit In FY2026

5 Surprising Realities for Investors in Singtel’s FY2026 Results How does a traditional telecommunications giant...
SGX-LISTED COMPANIES

JustCo Launches Its Flexible Workspace IPO

Why This Singapore Workspace Titan is Ready to Disrupt the APAC Office Market For the...
SGX-LISTED COMPANIES

Medinex 21% Profit Drop Hides A Surprising Operational Win In FY2026

Distinguishing GAAP Earnings from Operational Reality At first glance, Medinex Limited’s full-year results for the...
SGX-LISTED COMPANIES

Can A $9 Million Lifeline Save Green Build Technology – 1Q FY2026

A Company at the Crossroads Green Build Technology is currently a firm defined by contradiction....
SGX-LISTED COMPANIES

Nam Cheong Reports Improved Vessel Utilization In 1Q FY2026

What Nam Cheong’s 1Q 2026 Profit Really Tells Investors At first glance, Nam Cheong’s 1Q...
SGX-LISTED COMPANIES

Infinity Development Becomes A Capital Fortress Amidst 6M FY2026 Currency Friction

The Adhesive Holding the Global Footwear Market Together While consumers focus on the latest sneaker...
SGX-LISTED COMPANIES

Keong Hong 63% Revenue Dip Might Not Be The Full Story For Investors – 1H FY2026

The Construction Paradox When a company’s top line collapses by over 60%, the immediate market...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...